| Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder D Demontis, RK Walters, J Martin, M Mattheisen, TD Als, E Agerbo, ... Nature genetics 51 (1), 63-75, 2019 | 2280 | 2019 |
| The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. MJ Bohn, TF Babor, HR Kranzler Journal of studies on alcohol 56 (4), 423-432, 1995 | 1711 | 1995 |
| Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders PH Lee, V Anttila, H Won, YCA Feng, J Rosenthal, Z Zhu, EM Tucker-Drob, ... Cell 179 (7), 1469-1482. e11, 2019 | 1157 | 2019 |
| Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology N Mullins, AJ Forstner, KS O’Connell, B Coombes, JRI Coleman, Z Qiao, ... Nature genetics 53 (6), 817-829, 2021 | 996 | 2021 |
| Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial JC Garbutt, HR Kranzler, SS O’Malley, DR Gastfriend, HM Pettinati, ... Jama 293 (13), 1617-1625, 2005 | 841 | 2005 |
| Opioid-, cannabis-and alcohol-dependent women show more rapid progression to substance abuse treatment CA Hernandez-Avila, BJ Rounsaville, HR Kranzler Drug and alcohol dependence 74 (3), 265-272, 2004 | 759 | 2004 |
| A functional polymorphism of the μ-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients DW Oslin, W Berrettini, HR Kranzler, H Pettinati, J Gelernter, JR Volpicelli, ... Neuropsychopharmacology 28 (8), 1546-1552, 2003 | 734 | 2003 |
| Transancestral GWAS of alcohol dependence reveals common genetic underpinnings with psychiatric disorders RK Walters, R Polimanti, EC Johnson, JN McClintick, MJ Adams, ... Nature neuroscience 21 (12), 1656-1669, 2018 | 648 | 2018 |
| Topiramate for treating alcohol dependence: a randomized controlled trial BA Johnson, N Rosenthal, JA Capece, F Wiegand, L Mao, K Beyers, ... Jama 298 (14), 1641-1651, 2007 | 643 | 2007 |
| Give them prizes and they will come: Contingency management for treatment of alcohol dependence. NM Petry, B Martin, JL Cooney, HR Kranzler Journal of consulting and clinical psychology 68 (2), 250, 2000 | 633 | 2000 |
| Diagnosis and pharmacotherapy of alcohol use disorder: a review HR Kranzler, M Soyka Jama 320 (8), 815-824, 2018 | 616 | 2018 |
| Alcohol treatment utilization: findings from the National Epidemiologic Survey on Alcohol and Related Conditions E Cohen, R Feinn, A Arias, HR Kranzler Drug and alcohol dependence 86 (2-3), 214-221, 2007 | 605 | 2007 |
| Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African-and European-American and Japanese populations and in alcohol … J Gelernter, H Kranzler, JF Cubells Human genetics 101, 243-246, 1997 | 580 | 1997 |
| International meta-analysis of PTSD genome-wide association studies identifies sex-and ancestry-specific genetic risk loci CM Nievergelt, AX Maihofer, T Klengel, EG Atkinson, CY Chen, KW Choi, ... Nature communications 10 (1), 4558, 2019 | 540 | 2019 |
| Efficacy of naltrexone and acamprosate for alcoholism treatment: a meta‐analysis HR Kranzler, J Van Kirk Alcoholism: Clinical and Experimental Research 25 (9), 1335-1341, 2001 | 532 | 2001 |
| Largest GWAS of PTSD (N= 20 070) yields genetic overlap with schizophrenia and sex differences in heritability LE Duncan, A Ratanatharathorn, AE Aiello, LM Almli, AB Amstadter, ... Molecular psychiatry 23 (3), 666-673, 2018 | 488 | 2018 |
| Genome-wide association study of alcohol consumption and use disorder in 274,424 individuals from multiple populations HR Kranzler, H Zhou, RL Kember, R Vickers Smith, AC Justice, ... Nature communications 10 (1), 1499, 2019 | 481 | 2019 |
| A prospective cohort study investigating factors associated with depression during medical internship S Sen, HR Kranzler, JH Krystal, H Speller, G Chan, J Gelernter, C Guille Archives of general psychiatry 67 (6), 557-565, 2010 | 458 | 2010 |
| Genome-wide association study of alcohol dependence: significant findings in African-and European-Americans including novel risk loci J Gelernter, HR Kranzler, R Sherva, L Almasy, R Koesterer, AH Smith, ... Molecular psychiatry 19 (1), 41-49, 2014 | 423 | 2014 |
| Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. HR Kranzler, JA Burleson, P Korner, FK Del Boca, MJ Bohn, J Brown, ... The American journal of psychiatry 152 (3), 391-397, 1995 | 408 | 1995 |
Joel GelernterYale University School of MedicineVerified email at yale.edu
